Stocks and Investing Stocks and Investing
Thu, March 10, 2022
[ 12:00 AM ] - WOPRAI
Patrick Walravens Maintained (VERX) at Buy with Decreased Target to $28 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Joe Goodwin Maintained (VEEV) at Buy with Decreased Target to $265 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Liam Fitzpatrick Maintained (VALE) at Strong Buy with Increased Target to $20 on, Mar 10th, 2022
Wed, March 9, 2022
[ 12:00 AM ] - WOPRAI
Brad Milsaps Maintained (VBTX) at Buy with Decreased Target to $46 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Chris LaFemina Maintained (VALE) at Hold with Increased Target to $23 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Srikripa Devarakonda Initiated (VSTM) at Strong Buy and Held Target at $72 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Michael Carroll Maintained (VTR) at Buy with Increased Target to $62 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Kash Rangan Downgraded (WEAV) to Hold and Decreased Target to $13 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Michael Carroll Maintained (WELL) at Buy with Increased Target to $97 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Zekauskas Downgraded (VVV) to Hold and Decreased Target to $30 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (WSM) at Hold with Decreased Target to $80 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Allison Poliniak Cusic Maintained (XPO) at Buy with Increased Target to $119 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Jason Seidl Maintained (XPO) at Buy with Increased Target to $117 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Ryan MacDonald Downgraded (YEXT) to Hold on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Tom White Downgraded (YEXT) to Hold and Decreased Target to $5.25 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (UAA) at Buy with Decreased Target to $23 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Patrick Donnelly Maintained (STVN) at Strong Buy with Decreased Target to $23 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Timothy Daley Maintained (STVN) at Buy with Decreased Target to $21 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Derik De Bruin Maintained (STVN) at Strong Buy with Decreased Target to $24 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Drew Ranieri Maintained (STVN) at Buy with Decreased Target to $22 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Ross Gilardi Maintained (SWK) at Sell with Decreased Target to $140 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Candis Chan Upgraded (TAL) to Strong Buy on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Emily Chieng Upgraded (TECK) to Strong Buy and Held Target at $51 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Jack Allen Initiated (TSHA) at Buy and Held Target at $26 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Michael Carroll Maintained (DOC) at Hold with Decreased Target to $18 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
James Friedman Maintained (STNE) at Buy with Decreased Target to $28 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Ian Gillies Maintained (STN) at Strong Buy and Held Target at $74 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Bryan Spillane Maintained (CCEP) at Strong Buy with Decreased Target to $55 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Jacob Johnson Maintained (CDMO) at Buy with Decreased Target to $28 on, Mar 9th, 2022
[ 12:00 AM ] - WOPRAI
Mani Foroohar Maintained (BBIO) at Buy with Increased Target to $26 on, Mar 9th, 2022

Mani Foroohar Maintained (BBIO) at Buy with Increased Target to $26 on, Mar 9th, 2022


Published on 2024-10-27 20:01:00 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $25 to $26 on, Mar 9th, 2022.

Mani has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mani

  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $24 on, Tuesday, December 28th, 2021
Contributing Sources